US 11207314
Methods of treating cancer patients with farnesyltransferase inhibitors
granted A61KA61K31/4709A61K45/06
Quick answer
US patent 11207314 (Methods of treating cancer patients with farnesyltransferase inhibitors) held by Kura Oncology, Inc. expires Mon Dec 23 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Kura Oncology, Inc.
- Grant date
- Tue Dec 28 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 23 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K31/4709, A61K45/06, A61P, A61P35/00